好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Poster Session 02

Tuesday 05/01/07
11:30 AM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Child Neurology/Developmental Neurobiology, Clinical Neurophysiology, Epilepsy, MS and Related Diseases, Neurologic 好色先生, Peripheral Nerve
No CME available
Event Timeline
11:30 AM - 02:30 PM Abstract 001 - Non-Tuber Morphological Abnormalities in Tuberous Sclerosis Complex
11:30 AM - 02:30 PM Abstract 002 - Adverse Events Associated with Treatment of Infantile Spasms
11:30 AM - 02:30 PM Abstract 003 - How Abnormal Is the Overnight Sleep EEG in Children with Autism Spectrum Disorders?
11:30 AM - 02:30 PM Abstract 004 - Atomoxetine Induces Correlated Changes in Motor Cortex Inhibition and ADHD Symptoms
11:30 AM - 02:30 PM Abstract 005 - Efficacy of Extended-Release Dexmethylphenidate in Boys and Girls with ADHD: A Combined Analysis of Four 12-Hour Laboratory Classroom Studies
11:30 AM - 02:30 PM Abstract 006 - MELAS or Leigh Syndrome of Unknown Etiology; Think of the A13513G Mutation in the ND5 Gene of mtDNA.
11:30 AM - 02:30 PM Abstract 007 - BCS1L Mutations Block the Maturation of Respiratory Chain Complex III in Infantile Mitochondrial Encephalopathy
11:30 AM - 02:30 PM Abstract 008 - Endoplasmic Reticulum Stress and Altered Protein Trafficking in eIF2B Related Disorders
11:30 AM - 02:30 PM Abstract 009 - Diverse Clinical Presentations in Defects of Complex I Due to mtDNA Mutations
11:30 AM - 02:30 PM Abstract 010 - Clinical Profile in GJA12 Mutations: Nine Turkish Children
11:30 AM - 02:30 PM Abstract 011 - Sylvian Fissure Angle in Holoprosencephaly as a Predictor of Clinical Outcomes
11:30 AM - 02:30 PM Abstract 012 - Magnetization Transfer of Cervical Spinal Cord in Adrenomyeloneuropathy Relates Structure to Function
11:30 AM - 02:30 PM Abstract 013 - The Prognostic Value of Diffusion-Weighted MR Imaging for Cortical Blindness after Neonatal Hypoglycemia
11:30 AM - 02:30 PM Abstract 014 - Acute Transverse Myelitis in Childhood: Clinical and Radiological Features
11:30 AM - 02:30 PM Abstract 015 - Acute Disseminated Encephalomyelitis (ADEM) in Children
11:30 AM - 02:30 PM Abstract 016 - Pyruvate Carboxylase Deficiency: Mosaicism Correlates with Prolonged Survival
11:30 AM - 02:30 PM Abstract 017 - Is Benign Paroxysmal Torticollis Related to Mutations in the CACNA1A Gene?
11:30 AM - 02:30 PM Abstract 018 - A Role for Aspartoacylase in the Regulation of Oligodendrocyte Development in Canavan Disease
11:30 AM - 02:30 PM Abstract 019 - Aromatic L-amino Acid Decarboxylase Deficiency: Clinical, Biochemical and Genetic Characterization of an Unusually Mild Phenotype in Two Siblings
11:30 AM - 02:30 PM Abstract 021 - Atypical Progressive Supranuclear Palsy: Clinicopathological Correlation in a Brain Bank Program
11:30 AM - 02:30 PM Abstract 022 - Photophobia, Visual Hallucinations, and REM Sleep Behavior Disorder in Patients with Progressive Supranuclear Palsy and Corticobasal Syndrome: A Prospective Study
11:30 AM - 02:30 PM Abstract 023 - Distinct Clinical Phenotypes of Pathologically Proven Progressive Supranuclear Palsy: Richardson's Syndrome, PSP-Parkinsonism and PSP-Cerebral Cortical Dysfunction
11:30 AM - 02:30 PM Abstract 024 - Predominant Cortical Dysfunction in PSP-Like Guadeloupean Parkinsonism
11:30 AM - 02:30 PM Abstract 025 - Comparison of Cerebral Glucose Metabolism between the Patients with Amyotrophic Lateral Screrosis and Parkinsonism-Dementia Complex (PDC) in the Kii Peninsula of Japan
11:30 AM - 02:30 PM Abstract 026 - Head Injury with Amnesia and Risk of Multiple System Atrophy (MSA)
11:30 AM - 02:30 PM Abstract 027 - Quantification of Pyramidal Tract Pathology in Multiple System Atrophy (MSA)
11:30 AM - 02:30 PM Abstract 028 - Voxel Based Morphometry and Diffusion Tensor Imaging Study and Clinical Correlations in the Parkinson Variant of Multiple System Atrophy and Parkinson's Disease
11:30 AM - 02:30 PM Abstract 029 - Multiple System Atrophy: Morphometric Evaluation of the CNS Autonomic Nuclei in Patients with Sudden Deaths
11:30 AM - 02:30 PM Abstract 030 - Effects of Coenzyme Q10 in MSA, a Randomized, Placebo-Controlled, Double-Blind Pilot Study
11:30 AM - 02:30 PM Abstract 032 - Imaging Amyloid Deposition in Lewy Body Diseases
11:30 AM - 02:30 PM Abstract 033 - Voxel-Based Analyses of the Brain in De Novo Patients with Parkinson Disease: A T1-Weighted, Diffusion Tensor (DT) and Magnetization Transfer Ratio (MTR) MR Study
11:30 AM - 02:30 PM Abstract 034 - Impaired Presynaptic Inhibition in the Motor Cortex in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 035 - Trembling Legs during Freezing in Parkinson's Disease Are Associated with Multiple Postural Adjustments
11:30 AM - 02:30 PM Abstract 036 - Somesthesic Afferences Processing Impairement in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 037 - Patterns of Neuronal Activity in the Thalamus and Basal Ganglia Nuclei Correlated with Parkinsonian Motor Signs
11:30 AM - 02:30 PM Abstract 038 - Changes in the Subthalamic Oscillatory Beta Activity in Parkinson Disease during Sleep
11:30 AM - 02:30 PM Abstract 039 - Restoration of Normal Motor Control in Parkinson's Disease during REM Sleep
11:30 AM - 02:30 PM Abstract 040 - Assessment of Potential Pharmacodynamic Interaction between Rasagiline and Oral Tyramine in Healthy Subjects
11:30 AM - 02:30 PM Abstract 041 - Early and Progressive Disease Markers in MS; Results from a Large Cross-Sectional Spectroscopic Imaging Study at 3T
11:30 AM - 02:30 PM Abstract 042 - Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 043 - Validating Diffusion Tensor Imaging as a Measure of Physiologic Disruption
11:30 AM - 02:30 PM Abstract 044 - Retinal Nerve Fiber Layer Thickness Correlates with Whole Brain Atrophy in Multiple Sclerosis.
11:30 AM - 02:30 PM Abstract 045 - Does Medulla Oblongata Atrophy Reflect Spinal Cord Damage in MS?
11:30 AM - 02:30 PM Abstract 046 - Corpus Callosum Index: A 5-Year Prospective Follow-Up Study on Progressive Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 047 - Magnetic Resonance Spectroscopy Effects of Natalizumab: Single Center Results from the SENTINEL Study
11:30 AM - 02:30 PM Abstract 048 - Hemodynamic Changes in Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: A Dynamic Susceptibility Contrast Perfusion MR Imaging Study
11:30 AM - 02:30 PM Abstract 049 - Column-Specific Cervical Spinal Cord Magnetization Transfer Abnormality Correlates with Disability in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 050 - Retinal Nerve Fiber Layer Thickness Is Associated with Brain MRI Outcome in Multiple Sclerosis Patients
11:30 AM - 02:30 PM Abstract 051 - Cross-Center and Inter-Rater Reproducibility of Optical Coherence Tomography
11:30 AM - 02:30 PM Abstract 052 - Brain Pathways in Human Working Memory: Evidence from White Matter Lesions of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 053 - Clinical and MRI Characteristics of Progressive Multifocal Leukoencephalopathy (PML): Comparison with Relapsing-Remitting Multiple Sclerosis (RRMS)
11:30 AM - 02:30 PM Abstract 054 - Isotropic and Anisotropic Component Analyses of Normal-Appearing Brain Tissue in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 055 - Altered Functional and Structural Connectivities in Patients with Multiple Sclerosis: A FMRI and MR Tractography Study at 3 T
11:30 AM - 02:30 PM Abstract 056 - Short-Term Lesion Recovery - A Marker for MS Repair Potential?
11:30 AM - 02:30 PM Abstract 057 - Functional Brain Correlates of Neuropsychological Impairment in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 058 - Combined Brain MTR and H-MRS Multi-Modality Approach To Investigate Mechanism of Action of Interferon Beta and Glatiramer Acetate in RRMS
11:30 AM - 02:30 PM Abstract 059 - Cognitive Dysfunction Is Associated with "Occult" Structural Brain Damage in Benign Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 060 - A Longitudinal Diffusion Tensor MRI Study of Brain Damage Progression from the Earliest Clinical Stage of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 061 - Quantitative Evaluation of PIB-PET and FDG-PET in Early Cognitive Impairment
11:30 AM - 02:30 PM Abstract 062 - Callosal Morphometry, White Matter Hyperintensities, and Neurological Function in Nondmented Elderly
11:30 AM - 02:30 PM Abstract 063 - Diagnostic Comparison of PIB and MRI in Normal Aging, Amnestic MCI and AD
11:30 AM - 02:30 PM Abstract 064 - BOLD and Functional Perfusion MRI during Encoding in Medial Temporal Lobe Structures Distinguishes Alzheimer's Disease Genetic Risk
11:30 AM - 02:30 PM Abstract 065 - Amyloid Deposition in Relation to FDG Metabolism in Normal Aging
11:30 AM - 02:30 PM Abstract 066 - White Matter Hyperintensities (WMHs) in Mobility-Impaired Elderly
11:30 AM - 02:30 PM Abstract 067 - Sparing of Posterior Hippocampus and Parahippocampal Gyrus Is Associated with Beneficial Response to Cholinesterase Inhibition in Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 068 - Clinical Diagnosis, FDG-PET Imaging and Pathological Outcomes in Dementia
11:30 AM - 02:30 PM Abstract 069 - Patterns of Cortical Atrophy Obtained by Seriation Cluster Analysis Which Distinguish Subgroups of FTD, AD, and CBD.
11:30 AM - 02:30 PM Abstract 070 - Functional Imaging in a Behavioural Variant FTD Phenocopy
11:30 AM - 02:30 PM Abstract 071 - Restricted Dorsal [11C]PIB Uptake in a Patient with Early-Onset Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 072 - Patterns of Atrophy Differ between Amnestic MCI Converters vs Non-Converters
11:30 AM - 02:30 PM Abstract 073 - DTI Measures of Hippocampal Diffusivity Differ between Amnestic and Non-Amnestic MCI
11:30 AM - 02:30 PM Abstract 074 - Mechanisms Underlying Age-Related Decline in Working Memory
11:30 AM - 02:30 PM Abstract 075 - 1H MR Spectroscopy Markers of Cardiovascular Risk Factors in Non-Demented Elderly
11:30 AM - 02:30 PM Abstract 076 - Discrimination of Mild Cognitive Impairment from Mild Alzheimer's Disease by Human In Vivo Serotonin Metabolism Exploration
11:30 AM - 02:30 PM Abstract 077 - Magnetization Transfer Ratio and Cognitive Function in the General Population
11:30 AM - 02:30 PM Abstract 078 - Examination of Gray Matter Loss and FMRI Activation during Semantic Memory in Normal Aging and Amnestic Mild Cognitive Impairment
11:30 AM - 02:30 PM Abstract 079 - White Matter Hyperintensities and Fractional Anisotoropy Are Associated with Corpus Callosum Atrophy in Alzheimer Disease
11:30 AM - 02:30 PM Abstract 080 - Longitudinal Lobar Atrophy Rates in FTD, SD, and AD
11:30 AM - 02:30 PM Abstract 081 - How Accurate Is CT Angiogram (CTA) in Evaluating Large Intracranial Arterial Disease?
11:30 AM - 02:30 PM Abstract 082 - Transcranial Doppler Hemodynamic Indices and Risk of Stroke: The Rotterdam Study
11:30 AM - 02:30 PM Abstract 083 - Brain MRI Findings in Patients with FABRY Disease
11:30 AM - 02:30 PM Abstract 084 - Differential Patterns of Evolution in Acute Middle Cerebral Artery Infarction with Perfusion-Diffusion Mismatch: Atherosclerotic Versus Cardioembolic Middle Cerebral Artery Occlusion
11:30 AM - 02:30 PM Abstract 085 - Disturbed Connectivity within the Cortical Motor Network in Subcortical Stroke as Revealed by Functional Magnetic Resonance Imaging
11:30 AM - 02:30 PM Abstract 086 - The Accuracy of Transcranial Doppler in the Diagnosis of Middle Cerebral Artery (MCA) Stenosis: A Systematic Review
11:30 AM - 02:30 PM Abstract 087 - Correlation of MRI Lesion Growth with Stroke Mechanism and Clinical Outcomes
11:30 AM - 02:30 PM Abstract 088 - Feasibility of Superficial Temporal Artery as Input Artery in Cerebral Perfusion CT
11:30 AM - 02:30 PM Abstract 089 - Validation of Transcranial Doppler with CT Angiography in Acute Cerebral Ischemia
11:30 AM - 02:30 PM Abstract 090 - Diffusion Tensor Imaging and Neurological Recovery after Ischemic Stroke
11:30 AM - 02:30 PM Abstract 091 - [18F]-Fluoromisonidazole Positron Emission Tomography Specifically Predicts Early Lesion Progression in Acute Ischemic Stroke Patients
11:30 AM - 02:30 PM Abstract 092 - Diffusion-Weighted Imaging of Intramural Hematoma in Vertebral Artery Dissection
11:30 AM - 02:30 PM Abstract 093 - Recovery of Cerebral Hemodynamics Induces Normalization of Atypical Ipsilateral Motor Activity on fMRI
11:30 AM - 02:30 PM Abstract 094 - Detection of Acute Ischemia by 3.0 Tesla Diffusion Weighted MRI in Patients with Transient Global Amnesia
11:30 AM - 02:30 PM Abstract 095 - FMRI of Motor Learning Processes in Healthy and Hemiparetic Stroke Subjects
11:30 AM - 02:30 PM Abstract 096 - Neuro-Imaging in Stroke Subtype and Neurological Disorders (NISSAN) Study
11:30 AM - 02:30 PM Abstract 097 - Medullary Infarctions in 114 Consecutive Patients: Spatial and Temporal Features of MRI Findings
11:30 AM - 02:30 PM Abstract 098 - Long-Term Monitoring of Stroke Recovery after Transient Cerebral Ischemia in Mice Using [Italic]In Vivo[/Italic] and [Italic]Ex Vivo[/Italic] Diffusion Tensor MRI
11:30 AM - 02:30 PM Abstract 099 - Cerebrovascular Reactivity Assessment with MRI in Anesthetized Children
11:30 AM - 02:30 PM Abstract 100 - Reliability Estimates of fMRI Language Localization at 4T in Healthy and Left Middle Cerebral Artery (LMCA) Stroke Subjects
11:30 AM - 02:30 PM Abstract 102 - Diagnostic Ultrasound for Nerve Transection
11:30 AM - 02:30 PM Abstract 103 - Diagnostic Ultrasound in HMSN1B
11:30 AM - 02:30 PM Abstract 104 - Pattern of Therapy in Guillain-Barr[eacute] Syndrome: Analysis of a Large Database
11:30 AM - 02:30 PM Abstract 105 - A Descriptive Study of a Brazilian Population with Early Onset Chronic Peripheral Polyneuropathy (CPN)
11:30 AM - 02:30 PM Abstract 106 - Delay in Diagnosis of Neuralgic Amyotrophy (Idiopathic Brachial Neuritis) in Patients Evaluated by Non-Neurologists
11:30 AM - 02:30 PM Abstract 107 - Clinical and Electrophysiological Characteristics of Bell's Palsy at the Instituto Nacional de Ciencias Neurologicas (INCN), Lima, Peru
11:30 AM - 02:30 PM Abstract 108 - Intravenous Immunoglobulin Chromatography (IGIV-C) 10% for Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): An Adequately Powered Placebo-Controlled Clinical Trial To Evaluate Efficacy of IGIV-C 10% in CIDP
11:30 AM - 02:30 PM Abstract 109 - Chronic Inflammatory Demyelinating Polyneuropathy in a Pediatric Population, a 30 Year Review of Historical, Clinical, Laboratory and Therapeutic Factors
11:30 AM - 02:30 PM Abstract 110 - Health Status and Muscle Performance in Patients with CIDP at Long Term Follow up
11:30 AM - 02:30 PM Abstract 111 - Fentanyl Buccal Tablet (FBT) for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Neuropathic Pain: Efficacy and Patient Preference Outcomes from a Double-Blind, Placebo-Controlled Study
11:30 AM - 02:30 PM Abstract 112 - Presence of Conditioning Pain but Not Its Degree or Modality Determines DNIC Extent
11:30 AM - 02:30 PM Abstract 113 - Sustained Long Term Relief in Trigeminal and Other Neuralgias with TENS - A Pilot Study
11:30 AM - 02:30 PM Abstract 114 - Pudendal Neuropathy as an Etiology of Chronic Perineal Pain: Diagnosis and Treatment
11:30 AM - 02:30 PM Abstract 115 - A Population-Based Survey of Pain in Alberta: Features of Neuropathic Pain Are Common, Disabling, and Greatly Impair Quality of Life and Earning Potential
11:30 AM - 02:30 PM Abstract 116 - Pregabolin - A Report of Side-Effects Experienced in Intiating 350 Consecutive Patients in a Community Neurological Practice
11:30 AM - 02:30 PM Abstract 117 - Risk Factors for Early Diabetic Neuropathy
11:30 AM - 02:30 PM Abstract 118 - The Pathological Basis of Painless Diabetic Lumbosacral Radiculoplexus Neuropathy
11:30 AM - 02:30 PM Abstract 119 - Comparative Evaluation of Timed Vibration Detection as a Measure of Diabetic Peripheral Neuropathy
11:30 AM - 02:30 PM Abstract 120 - Inflammatory Mediators in Diabetic and Non-Diabetic Lumbosacral Radiculoplexus Neuropathy
11:30 AM - 02:30 PM Abstract 121 - The Utility of the Largest Lyapunov Exponent Versus Autocorrelation in Seizure Prediction
11:30 AM - 02:30 PM Abstract 122 - Characterization of Epileptogenic Networks in Tuberous Sclerosis Using Independent Component Analysis
11:30 AM - 02:30 PM Abstract 123 - Low Risk of Heating or Displacement of Titanium Skull Plates by Low Frequency Repetitive Transcranial Magnetic Stimulation (rTMS)
11:30 AM - 02:30 PM Abstract 124 - Motor and Mental Development of Infants of Mothers with Epilepsy
11:30 AM - 02:30 PM Abstract 125 - A Method for Identifying Patients with Psychogenic Nonepileptic Seizures Prior to Video-EEG Monitoring
11:30 AM - 02:30 PM Abstract 126 - Outcome of Epilepsy after Treatment at an Epilepsy Center
11:30 AM - 02:30 PM Abstract 127 - Leucoencephalopathy with Vanishing White Matter as a Cause of Progressive Myoclonus Epilepsy
11:30 AM - 02:30 PM Abstract 128 - Survey of Neurologists Regarding Mood Disorders in Persons with Epilepsy
11:30 AM - 02:30 PM Abstract 129 - Repetitive Versus Single Pulse Transcranial Stimulation for the Localization of Broca's Area
11:30 AM - 02:30 PM Abstract 130 - Utility of Neurophysiologic Intraoperative Monitoring in Posterior Fossa Arteriovenous Malformations Embolization: A Prospective Controlled Study
11:30 AM - 02:30 PM Abstract 131 - The Impact of Dexmedetomidine on Intraoperative Monitoring during Scoliosis Surgery: A Case Series Review
11:30 AM - 02:30 PM Abstract 132 - Motor Evoked Potentials Concurrently with Somatosensory Evoked Potentials: An Assessment Study
11:30 AM - 02:30 PM Abstract 133 - Peripheral and Central Conduction Changes Studied by Transcranial Magnetic Stimulation in Patients with Motor Neuron Disease
11:30 AM - 02:30 PM Abstract 134 - Responses of Masseter Muscles to Transcranial Magnetic Stimulation in Patients with Amyotrophic Lateral Sclerosis
11:30 AM - 02:30 PM Abstract 135 - Plasticity after Obstetrical Brachial Plexus Palsy: A Transcranial Magnetic Stimulation Study
11:30 AM - 02:30 PM Abstract 136 - Prediction of the Clinical Course of Early Multiple Sclerosis by Multimodal Visual, Motor and Somatosensory Evoked Potentials - A Prospective Study
11:30 AM - 02:30 PM Abstract 137 - Somatosensory Evoked Magnetic Fields in Mild and Moderate Head Trauma
11:30 AM - 02:30 PM Abstract 138 - Should There Be a Required Neurology Clerkship during Medical School? A Pilot Study
11:30 AM - 02:30 PM Abstract 139 - Evaluation of Assessment Methods and Grading of Medical Students in the Neurology Clerkship of the Massachusetts General Hospital, 1991 - 2006
11:30 AM - 02:30 PM Abstract 140 - Performance on the National Board of Medical Examiners Clinical Neurology Examination in Medical Students Who Complete Optional Bonus Essay Questions
11:30 AM - 02:30 PM Abstract 141 - A Poll of Neurology Clinics in Rural Illinois Regarding the Evaluation of Alzheimer Disease and the Availability of Related 好色先生al Material
11:30 AM - 02:30 PM Abstract 142 - Evaluation of a Novel 好色先生al Strategy for Integrating Evidence Based Neurology into Clinical Practice
11:30 AM - 02:30 PM Abstract 143 - Continuum for Neurology Resident Journal Club: Lifelong Learning Beginning Early in Neurology Training
11:30 AM - 02:30 PM Abstract 144 - Implementation of the 2006 AAN Parkinson Disease Practice Guidelines as a Teaching Curriculum Improves Medical Student and Resident Evidence-Based Knowledge
11:30 AM - 02:30 PM Abstract 145 - Attitudes toward Neurology in Undergraduate Students Who Will Be Applying to Medical School
11:30 AM - 02:30 PM Abstract 146 - Incentives and Barriers of Patients and Physicians for Participating in the National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)
11:30 AM - 02:30 PM Abstract 147 - Applicability of NINDS-Sponsored Studies to Community-Based Physician Involvement
11:30 AM - 02:30 PM Abstract 148 - Evaluating Acute Altered Mental Status: Are Incoming Interns Prepared?
11:30 AM - 02:30 PM Abstract 149 - Diagnostic Accuracy of Neurological Problems by Primary Care and Emergency Physicians
11:30 AM - 02:30 PM Abstract 150 - Reliability of Self Assessment of Cardiovascular Risk
11:30 AM - 02:30 PM Abstract 151 - The Challenge of Diagnostic Uncertainty: A Quantitative Approach to the Unexpected Test Result
Faculty Disclosures
Salvatore DiMauro, MD No disclosure on file
Leon J. Thal, MD No disclosure on file
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
David M. Ficker, MD, FAAN No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Beth A. Malow, MD, MS, FAAN Dr. Malow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Pharmaceuticals. The institution of Dr. Malow has received research support from National Institutes of Health. The institution of Dr. Malow has received research support from Department of Defense. The institution of Dr. Malow has received research support from PCORI.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Motric Bio. Dr. Jankovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Jankovic has received research support from Michael J Fox Foundation for Parkinson Research;. The institution of Dr. Jankovic has received research support from Dystonia Coalition. The institution of Dr. Jankovic has received research support from Parkinson's Foundation.
Mark Hallett, MD, FAAN Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Joseph R. Zunt, MD The institution of Dr. Zunt has received research support from NIH. Dr. Zunt has received publishing royalties from a publication relating to health care.
Peter D. Donofrio, MD, FAAN No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
David M. Simpson, MD, FAAN Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
David J. Capobianco, MD, FAAN No disclosure on file
Steven T. DeKosky, MD, FAAN Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. The institution of Dr. Evidente has received research support from Vima Pharmaceuticals. The institution of Dr. Evidente has received research support from Biohaven.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Clifford W. Shults, MD, FAAN No disclosure on file
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Kirk R. Daffner, MD, FAAN The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Walter J. Koroshetz, MD, FAAN Dr. Koroshetz has nothing to disclose.
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Andrew J. Kornberg, MD Dr. Kornberg has nothing to disclose.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Wade S. Smith, MD, PhD Dr. Smith has stock in MindRhythm, Inc. The institution of Dr. Smith has received research support from NIH. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Amer Alshekhlee, MD No disclosure on file
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Kenneth L. Tyler, MD, FAAN Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Omar A. Khan, MD, PhD No disclosure on file
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Alan Krumholz, MD, FAAN No disclosure on file
S. C. Johnston, MD, PhD, FAAN No disclosure on file
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Michael D. Privitera, MD, FAAN Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK life science. Dr. Privitera has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK life science. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Privitera has received research support from Neurelis. The institution of Dr. Privitera has received research support from Biohaven. Dr. Privitera has received research support from Neurava.
Randolph S. Marshall, MD, FAAN The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Alvaro Pascual-Leone, MD, PhD, FAAN Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation for serving as an employee of TI Solutions. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BitBrain. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AscenZion. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for TI Solutions. Dr. Pascual-Leone has or had stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care.
A. Gordon Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
J. R. Singleton, MD Dr. Singleton has received research support from NIH.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
James J. Riviello, Jr., MD Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Norman Latov, MD, PhD Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Peter B. Crino, MD, PhD Dr. Crino has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epigenyx. Dr. Crino has or had stock in Epigenyx.Dr. Crino has a non-compensated relationship as a Corporate Advisory Board member with Tuberous Sclerosis Complex Alliance that is relevant to AAN interests or activities.
Thomas A. Zeffiro, MD PhD No disclosure on file
William Jagust, MD No disclosure on file
Reisa A. Sperling, MD Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nervgen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vaxxinity. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Sperling has received research support from Eli Lilly. The institution of Dr. Sperling has received research support from Eisai. The institution of Dr. Sperling has received research support from NIH.
John G. Nutt, MD, FAAN No disclosure on file
G. F. Wooten, MD No disclosure on file
Joseph C. Masdeu, MD, PhD, FAAN Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Frederick Andermann, MD, FRCPC, FAAN No disclosure on file
Eric M. Wassermann, MD No disclosure on file
Hugo W. Moser, MD No disclosure on file
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Raphael Schiffmann, MD, FAAN No disclosure on file
Sid Gilman, MD, FAAN Dr. Gilman has nothing to disclose.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Keith Hyland, PhD No disclosure on file
William D. Freeman, MD, FAAN Dr. Freeman has nothing to disclose.
Adam S. Fleisher, MD No disclosure on file
Emily W. Tam, MD No disclosure on file
Abirami Muthukumaran, MD Dr. Muthukumaran has nothing to disclose.
Imad M. Najm, MD Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Matthew B. Stern, MD Dr. Stern has received personal compensation for serving as an employee of Mediflix, Inc. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stern has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Joelius Kurniawan, MD No disclosure on file
Joey English, MD, PhD No disclosure on file
Deepak Madhavan, MD No disclosure on file
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Stephen N. Gomperts, MD, PhD, FAAN Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bob's Last Stand. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Boston. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert connect. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care.
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Robert J. Baumann, MD, FAAN Dr. Baumann has nothing to disclose.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Neng C. Huang, MD No disclosure on file
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Jaime R. Lopez, MD An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
Neeraj Kumar, MD Dr. Kumar has nothing to disclose.
Robert G. Hart, MD No disclosure on file
Paul W. Brazis, MD, FAAN No disclosure on file
Scott L. Rauch, MD No disclosure on file
Brad A. Racette, MD, FAAN Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Cynthia Bodkin, MD, FAAN Dr. Bodkin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Bodkin has received research support from Massachusetts General Hospital. The institution of Dr. Bodkin has received research support from Alector LL. The institution of Dr. Bodkin has received research support from Atlantic research group. The institution of Dr. Bodkin has received research support from Amicus Therapeutics. The institution of Dr. Bodkin has received research support from Alexion. The institution of Dr. Bodkin has received research support from Anelixis. The institution of Dr. Bodkin has received research support from Medicinova INC. The institution of Dr. Bodkin has received research support from Ra Pharmaceuticals Inc.
Calixto Machado, MD, PhD, FAAN Dr. Machado has nothing to disclose.
Michael Cartwright, MD Dr. Cartwright has received publishing royalties from a publication relating to health care.
Angelos Katramados, MD Dr. Katramados has nothing to disclose.
Marie Vidailhet, MD, PhD No disclosure on file
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Meike Kasten, MD No disclosure on file
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Anne S. Lindblad, PhD No disclosure on file
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Aneesh B. Singhal, MD, FAAN An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Andrei V. Alexandrov, MD The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Orrin Devinsky, MD, FAAN Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
William W. Campbell, MD, MSHA, FAAN No disclosure on file
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Jun Li, MD, PhD, FAAN The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Michael Chopp, PhD No disclosure on file
Mohit Neema, MD No disclosure on file
Nuhad Abou Zeid, MD No disclosure on file
James M. Stankiewicz, MD, FAAN Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
No disclosure on file
Diana Apetauerova, MD Dr. Apetauerova has nothing to disclose.
Sharon Lamont No disclosure on file
Stephanie Scala No disclosure on file
Carl Hoegerl, MD, FAAN No disclosure on file
Tsutomu Nakada, MD, PhD No disclosure on file
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Luc Defebvre No disclosure on file
Philippe Derambure No disclosure on file
Alain Destee, MD, PhD No disclosure on file
Mary E. Jenkins, MD Dr. Jenkins has nothing to disclose.
Peachie N. Moore, BA No disclosure on file
David Devos The institution of Mr. Devos has received research support from Alterity.
Francis O. Walker, MD No disclosure on file
Valerie Cochen, MD No disclosure on file
Emmanuel Roze, MD, PhD Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Osamu Onodera, MD Dr. Onodera has nothing to disclose.
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Rosana H. Scola, MD Dr. Scola has nothing to disclose.
Lineu C. Werneck, MD No disclosure on file
Paulo J. Lorenzoni, MD Dr. Lorenzoni has nothing to disclose.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Tamara Vyshkina, PhD No disclosure on file
Manikum Moodley, MD, FAAN Dr. Moodley has nothing to disclose.
Daune L. MacGregor, MD, FAAN No disclosure on file
Gabrielle A. DeVeber, MD Dr. DeVeber has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for GDEV consultants inc.
William J. Logan, MD Dr. Logan has nothing to disclose.
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Hans Karbe, MD No disclosure on file
Christopher Kipps, MD, MBBS No disclosure on file
Sanjeev V. Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley India. The institution of Dr. Thomas has received research support from Government of India.
Gil D. Rabinovici, MD, FAAN Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Massimo Zeviani, MD, PhD No disclosure on file
Youn Young Chul, MD No disclosure on file
Marianna Bugiani No disclosure on file
Elda Judica, MD No disclosure on file
Paola Valsasina Paola Valsasina has nothing to disclose.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Angelo Ghezzi, MD No disclosure on file
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Antonella Ceccarelli No disclosure on file
Andrea Falini No disclosure on file
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Valeria Santos No disclosure on file
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Domenico Caputo, MD No disclosure on file
James T. Becker, PhD No disclosure on file
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Masatoyo Nishizawa, MD No disclosure on file
Hitoshi Takahashi No disclosure on file
Pablo Villoslada, MD, PhD, FAAN Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Jorge Sepulcre No disclosure on file
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Abu Nasar No disclosure on file
Ansgar Furst, PhD MS No disclosure on file
Ping Zhuang, PhD Dr. Zhuang has nothing to disclose.
Walter A. Kukull, PhD, FAAN The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Guy J. Buckle, MD No disclosure on file
Annie Lannuzel, MD Dr. Lannuzel has nothing to disclose.
Stephane Verhaeghe, MD No disclosure on file
Susan Gauthier, DO Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Charles R. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Gad Marshall, MD Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma USA Inc. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beth Israel Deaconness Medical Center. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publications.
Fen Bao Fen Bao has nothing to disclose.
Mai N. Nguyen-Huynh, MD Dr. Nguyen-Huynh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. Dr. Nguyen-Huynh has received research support from The Permanente Medical Group. Dr. Nguyen-Huynh has received research support from NIH. Dr. Nguyen-Huynh has a non-compensated relationship as a Member, Board of Directors with SEQUINS that is relevant to AAN interests or activities.
Jorida Coku No disclosure on file
Sara Shanske, PhD No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Michael Schupbach, MD No disclosure on file
Susan L. Connors, MD No disclosure on file
Angel Ball, PhD No disclosure on file
Ann M. Schmeichel Ann M. Schmeichel has nothing to disclose.
Alexandros C. Tselis, MD, PhD No disclosure on file
Megan L. Mackenzie, DO No disclosure on file
Tanvir Syed, MD No disclosure on file
Vanessa Troiani No disclosure on file
Melissa Tir No disclosure on file
Bruce R. Reed, PhD No disclosure on file
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Rosebud O. Roberts, MD No disclosure on file
Darren M. Farber, DO No disclosure on file
Goran Rakocevic, MD, FAAN Dr. Rakocevic has nothing to disclose.
Niels Bergsland Prof. Bergsland has nothing to disclose.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
John Young, MD No disclosure on file
Jay C. Erickson, MD No disclosure on file
Billie Ann Bixby No disclosure on file
Kenshi Terajima, MD, PhD No disclosure on file
Samuel Goldman, MD, MPH Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Littlepage Booth Leckman. The institution of Dr. Goldman has received research support from Michael J Fox Foundation. The institution of Dr. Goldman has received research support from US Department of Defense. The institution of Dr. Goldman has received research support from US Veterans Administration. The institution of Dr. Goldman has received research support from National Institutes of Health. The institution of Dr. Goldman has received research support from Health Resources and Services Administration. The institution of Dr. Goldman has received research support from American Academy of Pediatrics. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with University of California San Francisco. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with San Francisco Veterans Affairs Health Care System.
Grace S. Bhudhikanok, PhD No disclosure on file
Robert J. Ivnik, PhD No disclosure on file
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Glenn E. Smith, MD, PhD No disclosure on file
Maria M. Shiung, BA No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Chester Mathis No disclosure on file
William E. Klunk, MD, PhD No disclosure on file
Owen T. Carmichael, PhD No disclosure on file
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Joseph Herbert, MD No disclosure on file
Panayiotis Mitsias, MD The institution of Dr. Mitsias has received research support from European Union.
Claudio L. Bassetti, MD No disclosure on file
Rohit Das, MD, FAAN Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Virender Bhan, MD Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Stephen Weigand Stephen Weigand has nothing to disclose.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Brad Kemp Brad Kemp has nothing to disclose.
Scott Przybelski Scott Przybelski has nothing to disclose.
Mads H. Ravnborg, MD, DMSc No disclosure on file
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Mitsuhiro Yoshita, MD, PhD No disclosure on file
Nicholas W. Wood No disclosure on file
Madhuri Behari, MD No disclosure on file
Sumit Singh, MD No disclosure on file
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
Teresa Frohman, PA No disclosure on file
A. Gregory Sorensen, MD No disclosure on file
James B. Caress, MD, FAAN Dr. Caress has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing Inc.. Dr. Caress has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with US Department of Defense.
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Anabel R. Chade, MD No disclosure on file
William G. Ellis, MD No disclosure on file
Emmanuelle Apartis, MD No disclosure on file
Bradley T. Hyman, MD, PhD An immediate family member of Dr. Hyman has received personal compensation for serving as an employee of novartis. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for dewpoint. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Hyman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for avrobio. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dept of Justice. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cell Signalling. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Hyman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for sanofi. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vigil. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for voyager. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for dept of justice. Dr. Hyman has stock in dewpoint. The institution of Dr. Hyman has received research support from nih. The institution of Dr. Hyman has received research support from JPB. The institution of Dr. Hyman has received research support from Cure Alz Fund. The institution of Dr. Hyman has received research support from Tau consortium. The institution of Dr. Hyman has received research support from abbvie. The institution of Dr. Hyman has received research support from BMS.
John H. Growdon, MD No disclosure on file
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Frances E. Jensen, MD, FAAN Dr. Jensen has nothing to disclose.
Violaine K. Harris, PhD No disclosure on file
Bill Nikolov No disclosure on file
Dorene M. Rentz, PsyD Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Digital Cognition Technologies. Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurotrack.
Keith A. Johnson, MD Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervGen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. The institution of Dr. Johnson has received research support from National Institute on Aging. The institution of an immediate family member of Dr. Johnson has received research support from Alzheimer's Association. The institution of an immediate family member of Dr. Johnson has received research support from Eli Lilly and Co. The institution of Dr. Johnson has received research support from Eisai. The institution of an immediate family member of Dr. Johnson has received research support from Eisai.
Deanna Saylor, MD, MHS, FAAN Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Eva Andermann, MD, PhD No disclosure on file
Andreas V. Alexopoulos, MD, MPH Dr. Alexopoulos has nothing to disclose.
Lisa Silbert, MD, FAAN The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Warren W. Barker, MA No disclosure on file
Shara Steiner Brody No disclosure on file
Frederick J. Marshall, MD The institution of Dr. Marshall has received research support from CHDI. The institution of Dr. Marshall has received research support from Huntington Study Group.
Jessica D. Lee, MD, FAAN Dr. Lee has received personal compensation for serving as an employee of 好色先生. The institution of Dr. Lee has received research support from Janssen.
Patricio S. Espinosa, MD, MPH, FAAN Dr. Espinosa has nothing to disclose.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN Dr. Srinivasan has nothing to disclose.
Cathra Halabi, MD The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub. The institution of Dr. Halabi has received research support from NIH/NIDCD. The institution of Dr. Halabi has received research support from NIH/StrokeNet. Dr. Halabi has a non-compensated relationship as a Working Group Member with National Academies of Sciences, Engineering, and Medicine Action Collaborative on TBI Care that is relevant to AAN interests or activities. Dr. Halabi has a non-compensated relationship as a Working Group Member with NIH/StrokeNet Recovery and Rehabilitation Working Group that is relevant to AAN interests or activities.
Dominic B. Fee, MD, FAAN An immediate family member of Dr. Fee has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Spine Journal. The institution of Dr. Fee has received research support from ALS Association. The institution of an immediate family member of Dr. Fee has received research support from Veterans Administration.
Dominik S. Meier, PhD No disclosure on file
David H. Benninger, MD No disclosure on file
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Seth A. Smith, PhD Dr. Smith has nothing to disclose.
Sungho K. Cho, MD Dr. Cho has nothing to disclose.
Barbara Landesman, MD No disclosure on file
Mercedes Garces Sanchez No disclosure on file
Radhika Srinivasan, PhD No disclosure on file
Venkata S. Dandamudi, MD No disclosure on file
Joonmi Oh, PhD No disclosure on file
Mei Lu, MD No disclosure on file
Jong S. Kim, MD, PhD No disclosure on file
Sun U. Kwon, MD No disclosure on file
Dong-wha Kang, MD No disclosure on file
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Jennifer L. Cavitt, MD No disclosure on file
Richard A. Hughes, MD Dr. Hughes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Luis Salazar No disclosure on file
David Hojnacki, MD, FAAN Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Vijay K. Sharma, MD No disclosure on file
Eduardo Bonilla, MD No disclosure on file
Marc Malkoff, MD, FAAN Dr. Malkoff has nothing to disclose.
Marco Rovaris No disclosure on file
Michael H. Lev, MD Michael H. Lev, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda, Roche-Genetech. The institution of Michael H. Lev, MD has received research support from GE. Michael H. Lev, MD has received publishing royalties from a publication relating to health care.
Isabelle Arnulf, MD Dr. Arnulf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharma. Dr. Arnulf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE pharma. Dr. Arnulf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IDORSIA Pharma. Dr. Arnulf has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB Pharma. The institution of Dr. Arnulf has received research support from BIOPROJET pharma. The institution of Dr. Arnulf has received research support from VITALAIRE. The institution of Dr. Arnulf has received research support from French SLEEP Socity (SFRMS). The institution of Dr. Arnulf has received research support from Paris Brain Insitute. Dr. Arnulf has a non-compensated relationship as a scientific advisory with Jazz Pharma that is relevant to AAN interests or activities. Dr. Arnulf has a non-compensated relationship as a scientific advisory with Theranexus that is relevant to AAN interests or activities.
Fay B. Horak, PhD No disclosure on file
Kathleen A. Sterling No disclosure on file
Tarek Zakaria, MD Dr. Zakaria has nothing to disclose.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Pieter Van Doorn, MD The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Ingemar S. Merkies, MD No disclosure on file
Joseph Y. Matsumoto, MD Dr. Matsumoto has nothing to disclose.
Lenore J. Launer, PhD No disclosure on file
Roderick McColl, PhD No disclosure on file
Alain Kaelin-Lang, MD No disclosure on file
Kiran Sheikh No disclosure on file
Jennifer L. Cox, PhD Dr. Cox has nothing to disclose.
Domenico De Grandis, MD No disclosure on file
Mark T. Mackay, MBBS, FRACP No disclosure on file
Cory C. Toth, MD No disclosure on file
Shigeki Kuzuhara, MD, FAAN No disclosure on file
Peter J. Koudstaal, MD No disclosure on file
Albert Hofman, MD, PhD No disclosure on file
Monique M. Breteler, MD, PhD No disclosure on file
Amy Colcher, MD No disclosure on file
Leslie Wolfson, MD, FAAN No disclosure on file
Jin S. Hahn, MD No disclosure on file
Roberta Ravenni, MD No disclosure on file
David A. Wolk, MD, FAAN Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care.
Wendy G. Mitchell, MD Dr. Mitchell has nothing to disclose.
Max Wintermark, MD No disclosure on file
Kara Chisholm, MD No disclosure on file
Kyung-Hee Cho, MD No disclosure on file
A-Hyun Cho, MD, PhD No disclosure on file
Gregory N. Barnes, MD, PhD No disclosure on file
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Aaron L. Boster, MD Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Joel Stein, MD Dr. Stein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Stein has received personal compensation in the range of $0-$499 for serving as a Consultant for Dessintey. Dr. Stein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. The institution of Dr. Stein has received research support from BrainQ. The institution of Dr. Stein has received research support from Microtransponder.
Rafael Muniz, MD No disclosure on file
Kenneth R. Perrine, PhD No disclosure on file
Alexander Rotenberg, MD, PhD Dr. Rotenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotenberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rotenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple. Dr. Rotenberg has stock in PrevEp. Dr. Rotenberg has stock in Neuromotion Labs. The institution of Dr. Rotenberg has received research support from Encoded. The institution of Dr. Rotenberg has received research support from Roche. The institution of Dr. Rotenberg has received research support from Biomarin. The institution of Dr. Rotenberg has received research support from CRE Medical. The institution of Dr. Rotenberg has received research support from Neuroelectrics. The institution of Dr. Rotenberg has received research support from SSADH Foundation. The institution of Dr. Rotenberg has received research support from Loulou Foundation. Dr. Rotenberg has received intellectual property interests from a discovery or technology relating to health care.
Dong Wang, MD No disclosure on file
Darryl C. De Vivo, MD, FAAN Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Gerald Raymond, MD Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Robert W. Lindblad, MD No disclosure on file
Thomas A. Ala, MD No disclosure on file
Edward G. Hill, Jr., MD No disclosure on file
Christian Krarup, MD, DMSc, FRcP, FAAN Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Kwang W. Lee, MD No disclosure on file
Mario Mascalchi, MD No disclosure on file
William J. Nowack, MD, FAAN No disclosure on file
Jose A. Obeso, MD No disclosure on file
John A. Porter, MD No disclosure on file
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
N. Paul Rosman, MD, FAAN No disclosure on file
Bernard Laurent No disclosure on file
Ken Nagata, MD No disclosure on file
Steven L. Hoover, MD No disclosure on file
Murray S. Flaster, MD, PhD No disclosure on file
Jose C. Navarro, MD No disclosure on file
Dawn Eliashiv, MD, FAAN Dr. Eliashiv has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for eisai. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic's. Dr. Eliashiv has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. The institution of Dr. Eliashiv has received research support from NINDS. The institution of Dr. Eliashiv has received research support from Neuropace. Dr. Eliashiv has received publishing royalties from a publication relating to health care.
Walter F. Haupt, MD, Prof, FAAN No disclosure on file
Bernard Croisile, MD No disclosure on file
Charles A. Popeney, DO No disclosure on file
Gordon J. Gubitz, MD No disclosure on file
Norah S. Lincoff, MD Dr. Lincoff has nothing to disclose.
Ana M. Pardal, MD No disclosure on file
David Yarnitsky, MD Dr. Yarnitsky has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International association for the study of pain.
Jorge Iriarte, MD No disclosure on file
Laurie M. Douglass, MD No disclosure on file
Hector H. Garcia, MD, PhD The institution of Hector H. Garcia, MD, PhD has received research support from NIH.
Yasushi Kato, MD No disclosure on file
Paolo Del Dotto, MD No disclosure on file
Hian-Tat Ong, MD, MBBS No disclosure on file
Cengiz Yalcinkaya No disclosure on file
Johannes Jakobsen, MD, DMSci The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Won-Joo Kim, MD No disclosure on file
Alain Vighetto No disclosure on file
Silvia Montano, MD No disclosure on file
Amilton A. Barreira, MD No disclosure on file
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Yasumasa Kokubo, MD No disclosure on file
Sudeshna Mitra, MD No disclosure on file
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Peter Fuhr, MD, FAAN The institution of Dr. Fuhr has received research support from Roche.
Michiel Bos, MD No disclosure on file
Henning Andersen, MD Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Seung Hun Oh, MD No disclosure on file
Diana Richardson, MD No disclosure on file
Masato Kanazawa, MD, FAAN Dr. Kanazawa has nothing to disclose.
Roland G. Henry, PhD Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Kathleen M. Zackowski, PhD, OTR Dr. Zackowski has received personal compensation for serving as an employee of National MS Society.
Stacey Tay, MD No disclosure on file
Zuhal Yapici, MD Dr. Yapici has nothing to disclose.
Alex D. Cooper, MD No disclosure on file
Erica Grazioli, DO No disclosure on file
Scott McGinnis, MD Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Ivy Andersen, MD No disclosure on file
Mohamed B. Sultan, MD No disclosure on file
Peggy C. Martinez Esteban, MD Dr. Martinez Esteban has nothing to disclose.
Scott McPhee, PhD No disclosure on file
Gustavo Figueira, MD No disclosure on file
Pierre Krolak Salmon No disclosure on file
In Soo Moon, MD No disclosure on file
Arthur Partikian, MD Dr. Partikian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha Gene Therapies. Dr. Partikian has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sedgwick insurance. Dr. Partikian has stock in Taysha gene therapies. Dr. Partikian has stock in Roche. Dr. Partikian has stock in Stoke pharmaceutical . Dr. Partikian has received personal compensation in the range of $10,000-$49,999 for serving as a Neurology consultant with San Gabriel/Pomona Regional Center.
David Gloss, MD, FAAN Dr. Gloss has received personal compensation in the range of $500-$4,999 for serving as a DUR Board Member with WV Dept of Health and Human Services.
Yannie O. Soo, MD No disclosure on file
Cristina Granziera, MD, PhD The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Regina Schlaeger, MD The institution of Dr. Schlager has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. The institution of Dr. Schlager has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. The institution of Dr. Schlager has received research support from Gottfried and Julia Bangerter Rhyner Foundation. The institution of Dr. Schlager has received research support from Freiwillige Akademische Gesellschaft. The institution of Dr. Schlager has received research support from Stiftung zur Förderung der gastroenterologischen Forschung und allgemeinen Klinischen Forschung sowie der medizinischen Bildgebung. The institution of Dr. Schlager has received research support from Lorenzo Piaggio Foundation. The institution of Dr. Schlager has received research support from Biogen Inc.
Andrew W. Varga, MD No disclosure on file
Jamie Seaman No disclosure on file
Wei Liu, MD Dr. Liu has nothing to disclose.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Leena Amin No disclosure on file
Traci Clemons, PhD No disclosure on file
Andrew Aherne No disclosure on file
Manuel Alegre, MD, PhD No disclosure on file
Ashish Arora, MD No disclosure on file
Courtney Batt No disclosure on file
Esra Battaloglu Esra Battaloglu has nothing to disclose.
Larry Benowitz No disclosure on file
Annika Berger, MD No disclosure on file
Mohamad Chmayssani, MD No disclosure on file
Han Jin Cho No disclosure on file
Eliana Cardozo No disclosure on file
Hyemi Chong No disclosure on file
Jason Chu, MSc No disclosure on file
Luis Crovetto No disclosure on file
Daniel S. Birnbaum, DO No disclosure on file
Adrian Degardin, MD No disclosure on file
JaNean Engelstad JaNean Engelstad has nothing to disclose.
Monica Falautano Monica Falautano has nothing to disclose.
Gereon Fink No disclosure on file
Georgios Tsivgoulis, MD, FAAN Dr. Tsivgoulis has nothing to disclose.
Eliza M. Gordon-Lipkin, MD No disclosure on file
Thomas Harbo No disclosure on file
Jaesung Kim, MD No disclosure on file
Hye-Jin J. Kim No disclosure on file
Zachary Guss No disclosure on file
Casey Hoffman No disclosure on file
Anna Jansen No disclosure on file
Nilufer Kale Icen, MD Dr. Kale has nothing to disclose.
Nobutoshi Kawamura No disclosure on file
Claudia S. Kay, MD Dr. Kay has nothing to disclose.
Seung-Yeob Lee, MD No disclosure on file
Eun-Hui Lee No disclosure on file
Gha-hyun Lee No disclosure on file
Nicola Moscufo No disclosure on file
Edoardo Malfatti, MD Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
Smaranda Leu No disclosure on file
Yongjie Li No disclosure on file
John Listerud, MD No disclosure on file
Jason MacMore Jason MacMore has nothing to disclose.
Asif M. Paker, MD, MPH Dr. Paker has received personal compensation for serving as an employee of SwanBio Therapeutics.
Taizen Nakase Taizen Nakase has nothing to disclose.
Gabriel M. Napoli, MD Dr. Napoli has nothing to disclose.
Sona Narula, MD Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Nina Natarajan, MD The institution of Dr. Natarajan has received research support from Biogen, INc.
Phalgun Nori No disclosure on file
Mary Owen, RN, NP, MSN No disclosure on file
Khyung-Pil Park No disclosure on file
Katherine Podraza, MD, PhD Dr. Podraza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie .
Mathew J. Pulicken, MD, MHS Dr. Pulicken has nothing to disclose.
Bertrand Mercier No disclosure on file
Ju-Hong Min, MD No disclosure on file
Leah Marcotte No disclosure on file
Vanessa Marques No disclosure on file
Wilson Marques, Jr., MD Dr. Marques has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Angela Silva No disclosure on file
Gary Strangman No disclosure on file
Mari Tada, MD, PhD Dr. Tada has nothing to disclose.
Keiko Tanaka, MD, PhD Keiko Tanaka, MD, PhD has nothing to disclose.
Prashanthi Vemuri, PhD The institution of Dr. Vemuri has received research support from NIH.
Takashi Yamazaki, MD, PhD No disclosure on file
Hong Yang, MD No disclosure on file
Eppie Yiu, MD The institution of Dr. Yiu has received research support from Biogen. The institution of Dr. Yiu has received research support from Roche . The institution of Dr. Yiu has received research support from PTC. The institution of Dr. Yiu has received research support from Pfizer .
Werner Z'Graggen No disclosure on file
Christopher Gomez, MD, PhD Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Matt T. Bianchi, MD, PhD No disclosure on file
Piotr Olejniczak, MD, FAAN No disclosure on file
Duarte G. Machado, MD, FAAN Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal.
Brent P. Goodman, MD Dr. Goodman has nothing to disclose.
Shirley Triche No disclosure on file
Danish Bhatti, MD, FAAN Dr. Bhatti has nothing to disclose.
Tomoya Kubota No disclosure on file
Kimiko Domoto-Reilly, MD Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Ramy El Khoury, MD, FAAN No disclosure on file
Anhar Hassan, MBBCH, FRACP, FRCPI, FAAN The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Daniel J. MacGowan, MD, FAAN No disclosure on file
Cathrin M. Buetefisch, MD, PhD The institution of Dr. Buetefisch has received research support from NIH.
Dietrich Haubenberger, MD, FAAN Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Josef Parvizi, MD, PhD Dr. Parvizi has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Parvizi has or had stock in Ceribell.Dr. Parvizi has received intellectual property interests from a discovery or technology relating to health care.
James Stark, MD, FAAN Dr. Stark has nothing to disclose.
Sean Taylor, MD No disclosure on file
Armistead Williams III, MD Dr. Williams has nothing to disclose.
Tricia Y. Ting, MD No disclosure on file
Hongyan Li, MD, PhD, FAAN Dr. Li has nothing to disclose.
Con Yiannikas, MBBS Dr. Yiannikas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Marcelo Chaves No disclosure on file
Patrick Hecht, PhD Dr. Hecht has received personal compensation for serving as an employee of AbbVie. Dr. Hecht has stock in AbbVie.
Matthew C. Kiernan, MBBS, PhD, FRACP The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
Melih Tutuncu, MD No disclosure on file
M. M. Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Kevin A. Shapiro, MD No disclosure on file
Jesper Hagemeier No disclosure on file
Rezvan Rostami, MD No disclosure on file
Richard D. Dortch, PhD Dr. Dortch has nothing to disclose.
Mohamed Tom, MD Dr. Tom has received personal compensation for serving as an employee of Allegheny General Hospital . Dr. Tom has received personal compensation for serving as an employee of Mercy Hospital St. Louis .
Thomas M. Aune, PhD No disclosure on file
Fumin Tong, MD, PhD No disclosure on file
Amy Hellman, MD, FAAN The institution of Dr. Hellman has received research support from COBRE-NIH. The institution of Dr. Hellman has received research support from Neurocrine.
Scheherazade Le, MD Dr. Le has nothing to disclose.
Vieh M. Kung, MD Dr. Kung has nothing to disclose.
Charles F. Spurlock III, PhD Dr. Spurlock has received personal compensation for serving as an employee of Decode Health. Dr. Spurlock has received personal compensation for serving as an employee of New York University. Dr. Spurlock has received personal compensation for serving as an employee of IQuity Labs. Dr. Spurlock has stock in Decode Health. Dr. Spurlock has stock in IQuity Labs. The institution of Dr. Spurlock has received research support from National Institutes of Health.
Jon T. Willie, MD, PhD Jon T. Willie, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for AiM Medical. Jon T. Willie, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Jon T. Willie, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Lawrence C. Kenyon, MD, PhD No disclosure on file
Vibhash D. Sharma, MD, FAAN Dr. Sharma has nothing to disclose.
Dominique Monlezun, Jr No disclosure on file
Sana Ghafoor, MD No disclosure on file
Rebecca J. Thompson, MD No disclosure on file
Emily O. Ruether, MD No disclosure on file
Alyana Samai No disclosure on file
Christopher Sears No disclosure on file
Katherine Grosset No disclosure on file
Naveed Malek, MD Dr. Malek has nothing to disclose.
Robin N. Dharia, MD Dr. Dharia has nothing to disclose.
Stephen F. Holloway, MD, PhD No disclosure on file
Richard R. Murphy, MBChB, FAAN Dr. Murphy has nothing to disclose.
Kara Stavros, MD, FAAN Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Rhode Island Medical Society.
Nimeshan Geevasinga, MD, PhD No disclosure on file
Julia E. Staisch, MD Dr. Staisch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Staisch has received research support from Michael J Fox.
Joel H. Torres, MD No disclosure on file
Ron Schaumburg No disclosure on file
Jacqueline Sanchez No disclosure on file
Tara A. Kimbrough, MD Dr. Kimbrough has nothing to disclose.
Langan Ruth-Anne No disclosure on file
Pak Ho Au No disclosure on file
Ruben Carrasco Torres No disclosure on file
Sachin Paranjape No disclosure on file
Elena Meza Elena Meza has nothing to disclose.
Elaine Rudell No disclosure on file
Ranjeet K. Singh, MD No disclosure on file
Patricia Peterson No disclosure on file
Chantal Roy-Hewitson, MD Dr. Roy-Hewitson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Dr. Roy-Hewitson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Bernhard Voller, MD No disclosure on file
Ritvij Bowry, MD Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
Eslam H. Shosha, MD Dr. Shosha has nothing to disclose.
Monica M. Diaz, MD, MS The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Brian Burkett Mr. Burkett has nothing to disclose.
Julie J. Miller, MD, PhD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npj Precision Oncology. The institution of Dr. Miller has received research support from NINDS. The institution of Dr. Miller has received research support from American Cancer Society - IRG Pilot Grant. The institution of Dr. Miller has received research support from Karyopharm. The institution of Dr. Miller has received research support from NCI. The institution of Dr. Miller has received research support from American Brain Tumor Association.
Kiel Woodward, MD Dr. Woodward has nothing to disclose.
Uwe Zettl Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).
Kelly Lucchesi No disclosure on file
Joshua Lukas, MD Dr. Lukas has nothing to disclose.
Rahul R. Rao No disclosure on file
Pedro Balaguera, MD No disclosure on file
Stefan Baral No disclosure on file
Neal W. Langdon, MD No disclosure on file
Jessica B. Smith, MPH Ms. Smith has nothing to disclose.
Dilraj S. Sokhi, FRCP The institution of Dr. Sokhi has received research support from Genentech.
Olga Von Bismarck No disclosure on file